Form 4 for MMSI MERIT MEDICAL SYSTEMS INC
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003930 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-02 | 2023-03-01+ | MMSI | LAMPROPOULOS FRED P | Pres AND CEO, Dir | S - Sale | $69.88 | -20.7K | 992.9K | -2% | -$1.44M |
| D | 2023-03-02 | 2023-02-28 | MMSI | LAMPROPOULOS FRED P | Pres AND CEO, Dir | F - Tax | $70.58 | -12.0K | 1.01M | -1% | -$849.1K |
| D | 2023-03-02 | 2023-02-28 | MMSI | LAMPROPOULOS FRED P | Pres AND CEO, Dir | A - Grant | $0.00 | +27.2K | 1.03M | +3% | $0 |
| D | 2023-03-02 | 2023-02-28 | MMSI | LAMPROPOULOS FRED P | Pres AND CEO, Dir | A - Grant | $0.00 | +54.3K | 54.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, No Par Value | 2023-03-01 | S | D | 1,483 | $70.17 | 1,012,069 | D | — | — | (F3) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.44 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| 2 | Common | Common Stock, No Par Value | 2023-02-28 | F | D | 12,030 | $70.58 | 1,013,552 | D | — | — | (F2) These shares were not sold in an open-market transaction. |
| 3 | Common | Common Stock, No Par Value | 2023-02-28 | A | A | 27,159 | $0.00 | 1,025,582 | D | — | — | (F1) These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021. |
| 4 | Common | Common Stock, No Par Value | 2023-03-02 | S | D | 19,176 | $69.86 | 992,893 | D | — | — | (F4) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.6 to $70.1 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| 5 | Derivative | Non-qualified stock options (right to buy) | 2023-02-28 | A | A | 54,302 | $0.00 | 54,302 | D | $70.58 · 2024-02-28 to 2030-02-28 | 54,302 Common Stock | (F7) Becomes exercisable in equal annual installments of 25% commencing 02/28/2024. |